washingtonexaminer.com / .washingtonexaminer-com-congress / Page 3

Extending pharmaceutical patent terms to 30 years spurs crucial medical innovation and lowers drug pricing by spreading R&D costs.

Justice shouldn't end when sentences do. The Kayleigh's Law Act of 2026 provides lifetime protection for violent crime survivors.

Politically delayed federal research grants freeze medical trials and risk ceding American scientific leadership to China.

Republicans are trading the halls of Congress for the campaign trail. But many fear they have few achievements to tout as affordability drags them down.

Section 707 of the NDAA could save $4.5 billion in defense spending by offering troops alternative nicotine tools to quit smoking.

Outdated Soviet-era trade laws threaten key U.S. diplomatic gains in Central Asia unless Congress acts to repeal them permanently.

Gov. Andy Beshear made his first appearance with Zach Dembo at a June rally in Lexington, Kentucky, and has recorded digital content on his behalf.

Mizusawa will face Warner in November. Warner, who has refused to debate, is seeking a fourth term in the Senate and previously served as Virginia's governor.

House Minority Leader Hakeem Jeffries (D-NY) will get the win he needs to become speaker and avoid being ousted by his colleagues.

Deregulating AI poses a severe national security threat. America must enforce mandatory federal benchmarks to protect citizens.